Alcon AG vs DraftKings Inc — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while DraftKings Inc trades at $25.23 (market cap $12.58B). The key difference: Alcon AG is far larger — about 2.9× DraftKings Inc's market cap, and Alcon AG pays a 0.48% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals.
| ALC | DKNG | |
|---|---|---|
Market Cap | $36.44B | $12.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.12 | $48.23 |
52-Week Low | $62.02 | $20.72 |
Enterprise Value | $40.28B | $13.51B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →